GENE ONLINE|News &
Opinion
Blog

Reed Slater

WRITTEN BY Reed Slater

Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Gilead Sciences Works Alongside Westminster Drug Project To Eliminate Hepatitis C
2022-06-09
FDA Panel Recommends Novavax To Be Fourth Authorized COVID-19 Vaccine in America
2022-06-08
FDA Approves GSK’s MMR Vaccine Amidst Rise in Missed Vaccinations Among Children
2022-06-07
Proxygen Eligible For €495 Million in Molecular Glue Degrader Collaboration with Merck KGaA
2022-06-06
Sanofi and Sobi Receive Breakthrough Therapy Designation for Hemophilia A Drug
2022-06-02
Ultima Genomics Promises $100 Genome After Raising $600 Million
2022-06-01
The FDA is Investigating a Hepatitis A Outbreak Linked to Strawberries in the United States and Canada
2022-05-31
Novartis CAR-T Cell Therapy Receives FDA Approval for Third Indication to Treat Follicular Lymphoma
2022-05-30
Recounting 25 Years of Genetic and Human Diversity Discovery With deCODE Founder Kari Stefansson
2022-05-26
These Companies Are Harnessing Oncolytic Viruses to Target Cancer
2022-05-25
Learning From the COVID-19 Pandemic With Moderna CEO, Stéphane Bancel
2022-05-23
FDA Rejects Emergency Use Authorization for Common and Inexpensive Antidepressant COVID-19 Treatment
2022-05-20
Kelun Pharmaceuticals to Receive Up To $1.4 Billion From Merck in Lowkey Deal
2022-05-19
Evotec Leverages Sernova’s Cell Pouch to Develop Diabetes Stem Cell Treatment
2022-05-18
1 … 11 12 13 14 15
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top